Transendocardial delivery of autologous bone marrow mononuclear cells improved functional capacity and left ventricular function in patients with chronic heart failure.
Absolute Event Rate: 0% vs 0%
clinicaltrials.gov Identifier: NCT00824005.
Perin et al. (Sun,) reported a other. Transendocardial delivery of autologous bone marrow mononuclear cells improved functional capacity and left ventricular function in patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: